NCT01658826 - Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions

Genital Herpes

Interventions

DRUG

AIC316

100 mg oral administration

DRUG

Valacyclovir

500 mg oral administration

Trial Locations (4)

Indiana University School of Medicine, IU Infectious Diseases Research, Indianapolis

University of Texas Health Science Centre, Center for Clincial Studies, Houston

Westover Heights Clinic, Portland

University of Washington, Virology Research Clinic, Seattle